EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes (LN)

EBUS-guided TBNA for Molecular Diagnostic of Mediastinal Lymph Nodes

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00982605

Enrollment

Registered

2009-09-23

Start date

2009-10-31

Completion date

2011-01-31

Last updated

2009-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non Small Cell Lung Cancer

Brief summary

The purpose of this study is to perform molecular diagnostic in mediastinal lymph nodes of non-small cell lung cancer patients sampled by endobronchial ultrasound guided finde needle aspiration (EBUS-TBNA).

Detailed description

NSCLC is a common cancer. Accurate and early staging has a significant impact on outcome. EBUS-TBNA of involved mediastinal lymph nodes is critical. Molecular markers could improve mediastinal staging.

Interventions

PROCEDUREEBUS_TBNA

EBUS during bronchoscopy

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 80 Years

Healthy volunteers

Inclusion criteria

* Age ≥ 18 years * Samples are collected before surgery or before any therapy * ECOG 0 or 1 * Clinical stage I-II, T1-2, N0-1, M0) * Surgically respectable * Patient with enlarged med. lymphnodes (control group)

Exclusion criteria

* Previous RT/CHT * Previous or current cancer of other entity

Countries

Germany

Contacts

Primary ContactMichael Kreuter, MD

michael.kreuter@thoraxklinik-heidelberg.de49 / 6221 / 396

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026